David Fryauff

CDR David Fryauff serves as a Contracting Officer at the Naval Medical Research Center, where he leads the acquisition of advanced biomedical technologies critical to force health protection and operational readiness. His portfolio centers on the development and procurement of in-vitro diagnostic systems, field-deployable analytical tools, and infectious disease detection platforms designed for austere environments. CDR Fryauff ensures that all acquisitions align with the Center’s mission to deliver rapid, precision medical solutions to Navy and Marine Corps personnel, overseeing full lifecycle contracting from solicitation through award and performance management for high-complexity research and development projects. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted partner in the design and manufacturing of specialized diagnostic reagents and laboratory-based detection systems. CDR Fryauff maintains a consistent, long-term working relationship with this vendor, characterized by collaborative technical engagement and iterative contract modifications to meet evolving operational requirements. His procurement approach emphasizes technical rigor, regulatory compliance, and performance-based outcomes, fostering a partnership built on reliability and scientific alignment. CDR Fryauff’s contracting activity reflects a 100% non-set-aside preference, indicating a focus on technical capability and mission-critical performance over socioeconomic classifications. While small business participation is not formally prioritized in his portfolio, he ensures all vendors meet stringent quality, validation, and scalability standards required for military medical deployment. His procurement activity is exclusively focused on NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—reflecting deep expertise in diagnostic reagent development, molecular assay platforms, and laboratory diagnostic kits. He specializes in acquiring proprietary biosensors, pathogen-specific detection systems, and validated diagnostic workflows that support point-of-care and deployable laboratory testing in expeditionary settings.